{
    "eid": "2-s2.0-85142515210",
    "title": "In Schizophrenia, the Effects of the IL-6/IL-23/Th17 Axis on Health-Related Quality of Life and Disabilities Are Partly Mediated by Generalized Cognitive Decline and the Symptomatome",
    "cover-date": "2022-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pollution",
            "@code": "2310",
            "@abbrev": "ENVI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Health, Toxicology and Mutagenesis",
            "@code": "2307",
            "@abbrev": "ENVI"
        }
    ],
    "keywords": [
        "biomarkers",
        "deficit schizophrenia",
        "inflammation",
        "neuroimmune",
        "psychiatry",
        "tryptophan catabolites"
    ],
    "authors": [
        "Ali Fattah Al-Musawi",
        "Hussein Kadhem Al-Hakeim",
        "Zahraa Abdulrazaq Al-Khfaji",
        "Inas H. Al-Haboby",
        "Abbas F. Almulla",
        "Drozdstoj St Stoyanov",
        "Michael Maes"
    ],
    "citedby-count": 2,
    "ref-count": 68,
    "ref-list": [
        "Quality of life and its association with psychiatric symptoms and socio-demographic characteristics among people with schizophrenia: A hospital-based cross-sectional study",
        "Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia",
        "Quality of life in schizophrenic patients",
        "Schizophrenia and quality of life: How important are symptoms and functioning?",
        "Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients",
        "Needs and quality of life among patients with schizophrenia in five European centres",
        "Subject and observer-rated quality of life in schizophrenia",
        "Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression",
        "Social functioning and quality of life in schizophrenia patients--relationship with symptomatic remission and duration of illness",
        "The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia",
        "In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life",
        "Neurocognitive functioning and quality of life in patients with and without deficit syndrome of schizophrenia",
        "Quality of life and cognitive dysfunction in people with schizophrenia",
        "Is quality of life associated with cognitive impairment in schizophrenia?",
        "Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: A meta-analytic investigation",
        "Relationship of cognition and psychopathology to functional impairment in schizophrenia",
        "Cognitive impairment in schizophrenia",
        "False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes",
        "Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia",
        "The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: The IRS-CIRS Theory of Schizophrenia",
        "First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection",
        "The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence",
        "A new schizophrenia model: Immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "The interleukin-6/interleukin-23/Thelper-17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis",
        "The Schedule for the Deficit syndrome: An instrument for research in schizophrenia",
        "Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL)",
        "Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale",
        "The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and theoretical foundations",
        "The brief psychiatric rating scale",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "A rating scale for depression",
        "The assessment of anxiety states by rating",
        "The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery",
        "Controlling the false discovery rate: A practical and powerful approach to multiple testing",
        "Structural equation modeling with the SmartPLS. Brazil",
        "The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale",
        "Schizophrenia phenomenology revisited: Positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "Cognitive functioning and employment in severe mental illness",
        "Executive functioning in schizophrenia",
        "Disrupted prediction-error signal in psychosis: Evidence for an associative account of delusions",
        "Negative symptoms and cognitive deficits: What is the nature of their relationship?",
        "The neurobiology of cognition in schizophrenia",
        "Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis",
        "Neuropsychological status of subjects at high risk for a first episode of psychosis",
        "Executive attention impairment in first-episode schizophrenia",
        "CNS-specific synthesis of interleukin 23 induces a progressive cerebellar ataxia and the accumulation of both T and B cells in the brain: Characterization of a novel transgenic mouse model",
        "The role of Th17 cells in auto-inflammatory neurological disorders",
        "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation",
        "IL-21 stokes brain inflammation",
        "The Roles of IL-22 and Its Receptor in the Regulation of Inflammatory Responses in the Brain",
        "IL-22 induces an acute-phase response",
        "Interleukin-17 inhibits adult hippocampal neurogenesis",
        "In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia",
        "Association of Elements with Schizophrenia and Intervention of Selenium Supplements",
        "Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients",
        "Plasma magnesium levels in a population of psychiatric patients: Correlations with symptoms",
        "Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression",
        "Magnesium, schizophrenia and manic-depressive disease",
        "A brief note on serum calcium levels in schizophrenics and controls",
        "A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina",
        "Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims",
        "A functional interaction of sodium and calcium in the regulation of NMDA receptor activity by remote NMDA receptors",
        "Major neurocognitive psychosis: A novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin\u2019s and Bleuler\u2019s conceptions",
        "Serum BDNF levels, glycolipid metabolism in deficit schizophrenia: A case-control study",
        "Interactions Among Brain-Derived Neurotrophic Factor and Neuroimmune Pathways Are Key Components of the Major Psychiatric Disorders",
        "Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Karbala",
            "@id": "60251053",
            "affilname": "Al-Zahraa University for Women",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60251053",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Najaf",
            "@id": "60109789",
            "affilname": "The Islamic University, Najaf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109789",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kufa",
            "@id": "128755615",
            "affilname": "University of AL-Kafeel",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128755615",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Diwaniyah",
            "@id": "122983575",
            "affilname": "Al-Diwaniya Teaching Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122983575",
            "affiliation-country": "Iraq"
        }
    ],
    "funding": []
}